4899.0000 -132.10 (-2.63%)
NSE Aug 01, 2025 15:31 PM
Volume: 220.6K
 

4899.00
-2.63%
Motilal Oswal
period due to changes in the distribution policy, adjusting for which domestic sales growth was in early teens. US business sales were up 19% YoY at INR4.8b. Other international business sales grew 20% YoY to INR1.2b. Margins supported by lower operating cost: Gross margin shrank 300bp YoY to 58.2% on account of product mix change (competition intensified for high-margin products). However, the EBITDA margin expanded 400bp YoY to 12.8% due to lower other expenses (-580bp YoY)/employee cost (-120bp YoY). EBITDA was up 81% YoY at INR2.3b due to high revenue growth and...
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended